Richard Pulik

CFO at Roivant Sciences

Richard Pulik is the current CFO at Roivant Sciences. Richard has held this position since August 2021. Prior to that, they were the Global Head of BD&L and Portfolio Management for Oncology at Novartis from January 2012 to August 2021. Richard was also a key member of the Oncology Leadership Team that developed and executed strategies to enhance the value of the Novartis Oncology portfolio.

Before their time at Novartis, Richard Pulik worked as an investment banker for Bank of America / Merrill Lynch from January 2006 to December 2012. Richard then worked as an Associate for Monitor Group from January 2004 to December 2006, followed by UBS Investment Bank from June 2000 to August 2004.

Richard Pulik began their professional career as an Intern at Siemens from June 1999 to August 1999.

Richard Pulik received a B.S. in finance from The Wharton School and a BA in Economics from the University of Pennsylvania. Richard also attended Phillips Exeter Academy.

They work with Deya Corzo - Chief Medical Officer-In-Residence, Rakhi Kumar - CAO, and Matt Maisak - Chief Operating Officer, Roivant Platforms. Richard Pulik reports to Matthew Gline, CEO.

Links

Timeline

  • CFO

    Current role

View in org chart